๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The efficacy and tolerability of divalproex sodium in elderly demented patients with behavioral disturbances

โœ Scribed by Mark E. Kunik; Lucy Puryear; Claudia A. Orengo; Victor Molinari; Richard H. Workman Jr

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
85 KB
Volume
13
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

โœฆ Synopsis

Behavioral disturbances are commonly encountered in elderly demented patients. The records of all patients admitted to a geropsychiatric inpatient unit within a 2-year period who had a primary diagnosis of dementia and an accompanying behavioral disturbance treated with divalproex sodium were reviewed. Of the 13 patients identiยฎed, all tolerated divalproex sodium without signiยฎcant side-eects. General psychiatric symptoms, overall agitation, physical aggression and non-aggressive physical agitation decreased signiยฎcantly, but verbal agitation did not. Divalproex sodium is well tolerated and may be eective in ameliorating certain behavioral disturbances in elderly demented patients with agitation.

๐Ÿ“œ SIMILAR VOLUMES

Comparison of the tolerability and effic
Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice
โœ C. J. Kyle; Hans Erik Hรธpfner Petersen; Kerstin Fredricson Overรธ ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 107 KB ๐Ÿ‘ 2 views

The enhanced sensitivity of the elderly to the side effects produced by tricyclic antidepressants (TCAs), and the frequency and type of adverse events, have made the treatment of depression in this group difficult. The selective serotonin reuptake inhibitors (SSRIs) have been reported to produce sig

Memantine in severe dementia: results of
Memantine in severe dementia: results of the 9M-best study (benefit and efficacy in severly demented patients during treatment with memantine)
โœ B. Winblad; N. Poritis ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 175 KB ๐Ÿ‘ 1 views

## Objectives: To assess clinical efficacy and safety of memantine--an uncompetitive n-methyl-d-aspartate (nmda) antagonist--in moderately severe to severe primary dementia. ## Materials and methods: Dementia was defined by dsm-iii-r criteria and severity was assessed by the global deterioration

A randomised, double-blind comparison of
A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia
โœ Ingvar Karlsson; Jan Godderis; Carlos Augusto De Mendonรงa Lima; Harald Nygaard; ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 327 KB ๐Ÿ‘ 2 views

Depression is the most common psychiatric disorder among the elderly and in old age may interact with emotional and cognitive functioning. Depression in old age has been shown to be associated with degenerative changes in the brain. It is, therefore, important that in this patient population antidep

A multicentre, randomized, double-blind,
A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study
โœ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 139 KB ๐Ÿ‘ 2 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre